gimli
MEDANTA stock analysis context
GLOBAL HEALTH Stock Context for AI Screening
GLOBAL HEALTH LIMITED is a mid-cap stock in Healthcare. This page summarizes key screening signals for GLOBAL HEALTH, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about MEDANTAPrice
₹1,238.10
1M return
+11.35%
3M return
+9.57%
Market cap
₹33,267.61 cr
PE
59.78
ROE
+17.68%
RSI
65.94
Turnover
₹9.40 cr
Why it can matter in screens
- Momentum: MEDANTA is above 50DMA, above 200DMA; RSI is 65.94.
- Returns: 1M +11.35%, 3M +9.57%, 6M +0.91%.
- Liquidity: latest turnover is ₹9.40 cr.
- Valuation: PE 59.78, PB 8.35, ROE +17.68%, ROCE +20.33%.
- Growth: 3Y sales CAGR +18.83%, 3Y profit CAGR +34.87%.
Try these prompts
- Analyze GLOBAL HEALTH with valuation, momentum and industry peers
- Compare MEDANTA with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare MEDANTA with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.